85. Idiopathic interstitial pneumonia Clinical trials / Disease details
Clinical trials : 627 / Drugs : 443 - (DrugBank : 120) / Drug target genes : 99 - Drug target pathways : 212
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04362644 (ClinicalTrials.gov) | December 8, 2020 | 2/3/2020 | Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis | Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis | Idiopathic Pulmonary Fibrosis | Drug: PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714 | University of Alabama at Birmingham | NULL | Recruiting | 40 Years | 85 Years | All | 10 | Phase 1 | United States |